Delivering Critical Analytical Solutions for Biopharmaceutical Development and Manufacturing
Biopharmaceuticals are complex and heterogeneous molecules produced by living cells. Due to the nature of their production, detailed and rapid characterization is required to determine optimal growth conditions, purification protocols and formulation requirements that ensure efficacy and toxicity. Current testing approaches are cumbersome lacking the throughput and real-time analytical results that today’s rapidly growing biopharmaceutical industry desperately needs to make drug development and manufacturing decisions.
Intabio’s Blaze™ system was developed to address this unmet need. The Blaze platform performs a comprehensive analysis of antibody and protein biopharmaceutical product quality attributes with 100-fold higher throughput than traditional approaches in a proprietary imaged cIEF microchip technology integrated with identification by on-line mass spectrometry.
